Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease and rheumatic diseases, today announced that Spyre’s independent Compensation Committee of the Board of Directors approved the grant of stock options to purchase an aggregate of 30,200 shares of common stock of Spyre to five non-executive employees as equity inducement awards under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan, as amended (the “2018 Plan”). The stock options were approved on February 2, 2026 and were material to each employee’s acceptance of employment with Spyre, in accordance with Nasdaq Listing Rule 5635(c)(4).

The stock options were granted with a 10-year term and an exercise price equal to $32.75, the closing price per share of Spyre’s common stock as reported by Nasdaq on February 2, 2026. The options granted to the employees shall vest and become exercisable as to one-fourth (1/4th) of the shares subject to the respective options on the first anniversary of the employee’s start date, and one-forty-eighth (1/48th) of the shares subject to the respective options shall vest and become exercisable monthly thereafter, in each case, subject to continuous service with Spyre through the applicable vesting dates. The stock options are subject to the terms of the 2018 Plan.

About Spyre Therapeutics

Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases. Spyre’s pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23.

For more information, please visit http://spyre.com.

For Investors
:

Eric McIntyre
SVP of Finance and Investor Relations
Spyre Therapeutics
[email protected]



NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, The Netherlands and MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 217,000 of NewAmsterdam’s ordinary shares to four (4) non-executive new hires. The share options were granted as an inducement material to the employees’ acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).

The share options have an exercise price per share equal to $31.57, which represents the closing market price on the Nasdaq Stock Market of the Company’s ordinary shares on February 2, 2026, the grant date. The shares subject to the options will vest over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the shares vesting in a series of 36 equal monthly installments thereafter, subject to each employee’s continued service with NewAmsterdam on such vesting dates. The options are subject to the terms and conditions of the 2024 Inducement Plan and the terms and conditions of an option award agreement covering the grant.

About NewAmsterdam

NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple phase 3 studies, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP inhibitor, alone or as a fixed-dose combination with ezetimibe, as LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of CVD with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated.

Company Contact

Matthew Philippe
P: 1-917-882-7512
[email protected]



Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to five newly hired non-executive employees. The awards were made as an inducement material to each recipient’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement equity awards were granted effective as of February 2, 2026, and consist of non-statutory stock option awards to purchase up to an aggregate of 13,850 shares of Ocular’s common stock and a restricted stock unit awards representing the right to receive an aggregate of 4,600 shares of Ocular’s common stock. The stock option awards have an exercise price of $9.15 per share, equal to the closing price of Ocular’s common stock on The Nasdaq Global Market on the effective date of grant. Each of the stock option awards have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the one-year anniversary of the date of grant, and the remainder vesting in equal monthly installments over the three years after such date, subject to the recipient’s continued service to Ocular through the applicable vesting dates. Each of the restricted stock unit awards vest over three years, in equal annual installments, with the first annual installment vesting on February 2, 2027, and subject to the recipient’s continued service to Ocular through the applicable vesting dates.

The inducement equity awards are subject to the terms and conditions of the award agreements covering the grants and Ocular’s 2019 Inducement Stock Incentive Plan.

About Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is an integrated biopharmaceutical company committed to redefining the retina experience. AXPAXLI™ (also known as OTX-TKI), Ocular’s investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX™ proprietary bioresorbable hydrogel-based formulation technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic retinal disease, including non-proliferative diabetic retinopathy (NPDR).

Ocular’s pipeline also leverages the ELUTYX technology in its commercial product DEXTENZA®, an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery in adults and pediatric patients and ocular itching associated with allergic conjunctivitis in adults and pediatric patients aged two years or older, and in its investigational product candidate OTX-TIC, which is a travoprost intracameral hydrogel that has completed a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension. Ocular is currently evaluating next steps for the OTX-TIC program.

Follow the Company on its website, LinkedIn, or X.

DEXTENZA® is a registered trademark of Ocular Therapeutix, Inc. The Ocular Therapeutix logo, AXPAXLI™, ELUTYX™, and Ocular Therapeutix™ are trademarks of Ocular Therapeutix, Inc.

Investors & Media

Ocular Therapeutix, Inc.
Bill Slattery
Vice President, Investor Relations
[email protected]



A10 Networks to Host Investor Day on February 19, 2026

A10 Networks to Host Investor Day on February 19, 2026

Event to detail A10’s long-term growth framework across Legacy Networking, Next-Generation Networking, and Security, to include Live Webcast and Replay

SAN JOSE, Calif.–(BUSINESS WIRE)–
A10 Networks (NYSE: ATEN), a leading provider of secure application services and solutions, today announced it will host an Investor Day in San Francisco on Thursday, February 19, 2026, at the Fairmont San Francisco. The Company’s executive leadership team will outline A10’s long-term growth framework across Legacy Networking, Next-Generation Networking, and Security. The event will include a live webcast and replay and is intended to provide investors with a deeper view into A10’s strategy, portfolio evolution, and financial priorities.

The Investor Day will be held in person, and a live webcast will be available for those who are unable to attend on site.

Attendance and Registration

In-person attendance: Check-in and lunch will begin at 12:00 p.m. Pacific Time, followed by the program beginning at 1:00 p.m. Pacific Time at the Fairmont San Francisco. Registration is required. Investors interested in attending in person may register here: https://www.eventcreate.com/e/a10

Webcast: A live webcast will begin streaming at 1:00 p.m. Pacific Time (4:00 p.m. Eastern Time) and is expected to conclude at approximately 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time). Those who plan to participate virtually may register for the webcast here: https://edge.media-server.com/mmc/p/vyoed9cd

A replay of the webcast and presentation materials will be available in the “Investors Relations” section of the company’s website following the event.

About A10 Networks

A10 Networks (NYSE: ATEN) delivers secure application and network solutions that protect, optimize, and scale business-critical systems across on-premises, hybrid cloud, and edge environments. Our portfolio enables large enterprises, service providers, and cloud platforms worldwide to deliver performance, reliability, and protection against cyber threats, while preparing their networks for the demands of AI and next-generation applications. Founded in 2004 and headquartered in San Jose, California, A10 Networks serves over 7,000 global customers. For more information, visit A10networks.com and follow us at A10Networks.

The A10 logo and A10 Networks are trademarks or registered trademarks of A10 Networks, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

Source: A10 Networks, Inc.

Investor Contact:

Rob Fink or Tom Baumann

FNK IR

646.809.4048 / 646.349.6641

[email protected]

David Schroeder

VP, Corporate Development

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Data Management Security Apps/Applications Technology Software Networks

MEDIA:

Amaze CEO Aaron Day, Featured on Escaping The Drift with John Gafford, Discusses the Evolution of Creator-Led Commerce

In a just-released podcast appearance, Aaron Day discusses AI technology, infrastructure, and the future of creator-led shopping experiences

NEWPORT BEACH, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered commerce, today announced CEO Aaron Day was featured on an episode of Escaping The Drift with John Gafford where he discussed the future of creator-led commerce and how social platforms are redefining how products are sold online.

In the episode, titled “The Future of Creator Commerce: How to Monetize Your Passion,” Day shared his journey from a senior role at Canva to leading Amaze, a company that enables creators to create digital storefronts and sell directly within platforms such as YouTube, TikTok, and Instagram. Day and host John Gafford explore the strategic evolution of the creator economy, the rise of first-party (1P) branding, the growing power of niche influencers, and how Amaze leverages its AI technology to transform social engagement into physical products at global scale.

The episode is available on Apple, Spotify, and YouTube.

For investor information, please contact [email protected]

For press inquiries, please contact [email protected]

About Amaze:

Amaze Holdings, Inc. is an end-to-end, creator-powered commerce platform offering tools for seamless product creation, advanced e-commerce solutions, and scalable managed services. By empowering anyone to “sell anything, anywhere,” Amaze enables creators to tell their stories, cultivate deeper audience connections, and generate sustainable income through shoppable, authentic experiences. Discover more at www.amaze.co.

About Escaping the Drift Podcast:

Escaping the Drift with John Gafford, part of the True Native Media family of podcasts, is a top 20 podcast under the Business category with over a million monthly downloads per episode and a massive reach over social media. Learn more at www.escapingthedrift.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements relate to future events and developments or to our future operating or financial performance, are subject to risks and uncertainties and are based on estimates and assumptions. Forward-looking statements may include, but are not limited to, statements about our planned acquisitions, strategies, initiatives, growth, revenues, expenditures, the size of our market, our plans and objectives for future operations, and future financial and business performance. These statements can be identified by words such as such as “may,” “might,” “should,” “would,” “could,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue,” and are based our current expectations and views concerning future events and developments and their potential effects on us.

These statements are subject to known and unknown risks, uncertainties and assumptions that could cause actual results to differ materially from those projected or otherwise implied by the forward-looking statement. These risks include: our ability to execute our plans and strategies; our limited operating history and history of losses; our financial position and need for additional capital; our ability to attract and retain our creator base and expand the range of products available for sale; we may experience difficulties in managing our growth and expenses; we may not keep pace with technological advances; there may be undetected errors or defects in our software or issues related to data computing, processing or storage; our reliance on third parties to provide key services for our business, including cloud hosting, marketing platforms, payment providers and network providers; failure to maintain or enhance our brand; our ability to protect our intellectual property; significant interruptions, delays or outages in services from our platform; significant data breach or disruption of the information technology systems or networks and cyberattacks; risks associated with international operations; general economic and competitive factors affecting our business generally; changes in laws and regulations, including those related to privacy, online liability, consumer protection, and financial services; our dependence on senior management and other key personnel; and our ability to attract, retain and motivate qualified personnel and senior management.

Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other future filings and reports that we file with the Securities and Exchange Commission (SEC) from time to time. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the press release. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments.



DraftKings Expands Prediction Markets Catalog in Deal With Crypto.com

New exchange connection brings first player-specific sports event contracts to DraftKings Predictions

BOSTON, Feb. 06, 2026 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today announced an agreement with Crypto.com | Derivatives North America (“Crypto.com”), a global cryptocurrency platform and CFTC-regulated derivatives exchange, to broaden the prediction markets available on DraftKings Predictions. The expansion marks the first player-specific sports event contracts offered on DraftKings Predictions for both the NFL and NBA, extends the platform’s prediction markets offerings, and establishes the foundation for future categories, including politics.

“We’re continuing to build momentum behind DraftKings Predictions by leveraging our expertise across sports and technology and integrating additional CFTC-regulated exchanges like Crypto.com,” said Jeanine Hightower-Sellitto, Senior Vice President and General Manager of DraftKings Predictions. “This collaboration meaningfully expands customer access to trade on sports and a broader range of prediction markets and also reinforces our focus on delivering a more comprehensive and engaging experience as the product continues to evolve.”

As part of this expansion, DraftKings Predictions adds breadth across sports prediction markets in the states where the product is available, spanning soccer, MMA, golf, boxing, tennis, and the Olympic Games, to complement the existing sports and financial markets provided by CME Group. In addition to the wider scope of sports prediction markets, Crypto.com is expected to support DraftKings Predictions’ introduction of new event contract categories, including culture, entertainment, and politics. Additionally, DraftKings Predictions will integrate Railbird Exchange in the coming months, further strengthening its offering.

“Crypto.com continues to lead the way with innovative collaboration. Connecting with DraftKings, a household name in sports, is an important milestone for us because it allows us to not only expand access to prediction markets in sports, but it grows our distribution to prediction markets on cryptocurrencies, financials, companies, politics, culture, entertainment and beyond,” said Travis McGhee, Global Head of Predictions at Crypto.com. “We are thrilled to work with DraftKings, and we look forward to creating an engaging experience together for customers across the country.”

DraftKings Predictions allows eligible customers to make predictions through federally regulated event contracts, including sports event contracts in states such as California, Florida, Georgia, and Texas. The platform also integrates DraftKings’ Responsible Trading program with tools and resources available directly within the standalone app and at predictions.draftkings.com.

Customers can experience DraftKings Predictions and learn more by downloading the app for iOS or Android.

About DraftKings

DraftKings Inc. is a digital sports entertainment and gaming company created to be the Ultimate Host and fuel the competitive spirit of sports fans with products that range across daily fantasy, regulated gaming and digital media. The company is headquartered in Boston and was launched in 2012 by Jason Robins, Matt Kalish and Paul Liberman. DraftKings’ mission is to make life more exciting by responsibly creating the world’s favorite real-money games and betting experiences. DraftKings Sportsbook is live with mobile and/or retail sports betting operations pursuant to regulations in 30 states, Washington, D.C., Ontario, Canada, and Puerto Rico. The Company operates iGaming pursuant to regulations in five states and in Ontario, Canada under its DraftKings brand and pursuant to regulations in four states and in Ontario, Canada, under its Golden Nugget Online Gaming brand. DraftKings also owns Jackpocket, the leading digital lottery courier app in the United States. DraftKings’ daily fantasy sports product is available in 44 states, the District of Columbia and certain Canadian provinces. DraftKings’ wholly-owned subsidiary GUS III Inc. (d/b/a DraftKings Predictions) also operates DraftKings Predictions, a standalone app and web product offering federally regulated event contracts under CFTC oversight. DraftKings is both an official sports betting and daily fantasy partner of the NFL, NHL, PGA TOUR, WNBA and UFC, as well as an official daily fantasy partner of NASCAR, an official sports betting partner of the NBA and an authorized gaming operator of MLB. In addition, DraftKings owns and operates DraftKings Network, a multi-platform content ecosystem. DraftKings is committed to being a responsible steward of this new era in real-money gaming by developing and promoting educational information and tools to help all players enjoy our games responsibly.

About Crypto.com

Founded in 2016, Crypto.com is trusted by millions of users worldwide and is the industry leader in regulatory compliance, security and privacy. Our vision is simple: Cryptocurrency in Every Wallet™. Crypto.com is committed to accelerating the adoption of cryptocurrency through innovation and empowering the next generation of builders, creators, and entrepreneurs to develop a fairer and more equitable digital ecosystem. Crypto.com | Derivatives North America (CDNA) is an affiliate of Crypto.com and is registered with the Commodity Futures Trading Commission (CFTC) as a designated contract market and derivatives clearing organization; CDNA offers the trading and clearing of sports prediction market contracts, as well as prediction market contracts on cryptocurrencies, financials, companies, politics, culture, and entertainment, including through intermediaries such as DraftKings Predictions.

Contacts

[email protected]



@DraftKingsNews


[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c173f1b0-6ff8-47fd-9261-0a050df1aa5f



PropStream’s Innovation Streak Continues With Sixth HousingWire Tech100 Honor

PropStream’s Innovation Streak Continues With Sixth HousingWire Tech100 Honor

LAKE FOREST, Calif.–(BUSINESS WIRE)–
PropStream, the all-in-one real estate lead generation platform, announced today that it has been named a 2026 Tech100 honoree by HousingWire. This marks the sixth consecutive year PropStream has earned a spot on HousingWire’s prestigious Tech100 list, underscoring the company’s sustained commitment to innovation and industry impact.

The annual Tech100 program recognizes the most innovative and influential technology companies in the real estate and mortgage industries. Honorees are selected for their ability to solve real-world challenges, improve efficiency, and empower professionals to adapt and succeed in an evolving market.

“The 2026 Tech100 honorees represent the companies pushing housing forward in real, measurable ways,” said Sarah Wheeler, Editor-in-Chief at HousingWire. “They’re building technology that solves core industry challenges, from operational efficiency to better consumer experiences, and setting a higher standard for what innovation in housing truly looks like.”

As the Tech100 program continues to raise the bar for innovation, PropStream’s sixth consecutive recognition reflects consistent execution and long-term focus. Over the past year, PropStream has advanced its platform by unifying property records, intelligence, and outreach through the acquisition of BatchDialer, resulting in an integrated dialer, enhanced skip-tracing capabilities (through third-party providers), and simplified lead-to-dial workflows. Alongside continued investment in PropStream Intelligence™, these updates reinforce PropStream’s focus on delivering practical, scalable technology that helps real estate professionals operate with greater speed, clarity, and confidence in a changing market.

“Earning HousingWire Tech100 recognition for the sixth year in a row represents a meaningful benchmark for PropStream,” said Brian Tepfer, President of PropStream. “It reflects years of dedicated investment in technology that helps real estate professionals execute more effectively and contributes to a stronger, more connected industry. Our focus remains on turning insights into action by delivering technology and services that are intuitive, actionable, and built for how the industry operates today.”

Looking ahead to 2026 and beyond, PropStream remains committed to advancing real estate technology through a more unified, intuitive, and connected all-in-one platform that helps professionals work more efficiently, scale faster, and uncover new opportunities.

About PropStream: PropStream, a Stewart company, is a premier all-in-one real estate lead generation platform that empowers real estate professionals with unmatched aggregated data quality, accuracy, marketing tools, and dialer. Founded in 2006, PropStream provides insights for over 160 million properties nationwide, leveraging PropStream Intelligence, predictive real estate records, and proprietary AI-driven analytics to support advanced filtering, featuring over 165 filters and 20 pre-built Lead Lists. PropStream helps real estate professionals identify the best off-market opportunities, comps, and connect with sellers more efficiently. PropStream was acquired by Stewart Information Services Corporation Technology Holdings (NYSE: STC) in November 2021 and has been named a HousingWire Tech 100 Honoree for six consecutive years since 2021.

About HousingWire: HousingWire is an information services company that provides unique data and research, respected business journalism, and must-attend events for housing leaders to use to advance their understanding and business outcomes. Our vision is a world in which housing leaders have a complete view of the housing market and a broad community of peers with whom they can connect. We are committed to delivering the data, analytics, media, and events that advance this vision.

PropStream Marketing Department

(877) 204-9040

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Construction & Property Internet Artificial Intelligence Data Management Technology Apps/Applications Residential Building & Real Estate

MEDIA:

Logo
Logo

AM Best Affirms Credit Ratings of Prudential Financial, Inc. and Its Life/Health Subsidiaries

AM Best Affirms Credit Ratings of Prudential Financial, Inc. and Its Life/Health Subsidiaries

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa-” (Superior) of the life/health insurance subsidiaries of Prudential Financial, Inc. (PFI) (Newark, NJ) [NYSE: PRU], collectively referred to as Prudential. Concurrently, AM Best has affirmed the Long-Term ICR of “a-” (Excellent) of PFI and all Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of the group. The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the companies and ratings.)

The ratings reflect Prudential’s balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, very favorable business profile and very strong enterprise risk management.

Prudential’s very strong balance sheet assessment is supported by its very strong Best’s Capital Adequacy Ratio (BCAR) assessment, which is reflective of the group’s efforts balance sheet over the past few years. The group’s investments supporting its insurance liabilities are of the highest quality with moderate exposure to below investment grade bonds, mortgage loans and structured securities. The insurance entities leverage the expertise of PFI’s global asset manager, PGIM. Furthermore, Prudential’s access to capital markets and additional financial flexibility through PFI adds to its balance sheet strength. The organization exhibits strong liquidity measures and more-than-adequate cash and short-term security holdings as of PFI’s last reported quarter ending Sept. 30, 2025. One of Prudential’s offsetting balance sheet strength attributes is the reliance on internal captives. Internal reinsurance allows the group to manage its capital more efficiently and more effectively on an economic basis and enables an aggregation and transfer of risk; however, AM Best notes that this partially reduces the overall quality of the group’s capital.

Prudential offers a very wide range of products in the life/annuity product space that is complemented by the asset management services offered by PGIM. AM Best recognizes its leading market positions in the pension risk transfer business, institutional stable value, indexed universal life and variable universal life protection and accumulation products. Strong sales have supported the group’s operating performance, which is driven by its diversified business lines of both insurance from its individual and group segments and non-insurance asset management services. Furthermore, AM Best recognizes Prudential’s stable net investment income growth over the past five years.

The FSR of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) have been affirmed with stable outlooks for the following subsidiaries of Prudential Financial, Inc.:

  • The Prudential Insurance Company of America

  • Pruco Life Insurance Company

  • Pruco Life Insurance Company of New Jersey

The following Long-Term IRs have been assigned with stable outlooks:

PRICOA Global Funding I— “aa-” (Superior) program rating

–“aa-” (Superior) on $500 million 4.35% medium term notes, due 2030

–“aa-” (Superior) on $500 million 4.65% medium term notes, due 2033

The following Short-Term IRs have been affirmed:

Prudential Financial, Inc.—

— AMB-1 (Outstanding) on $3 billion commercial paper program

Prudential Funding, LLC—

— AMB-1 (Outstanding) on $6 billion commercial paper program

PRICOA Short-Term Funding, LLC—

— AMB-1 (Outstanding) on $3 billion Funding Agreement Backed Commercial Paper

The following Long-Term IRs have been affirmed with stable outlooks:

Prudential Financial, Inc.—

— “a-” (Excellent) on JPY 23.0 billion 2.62% senior unsecured notes, due 2026

— “a-” (Excellent) on JPY 17.5 billion 2.76% senior unsecured notes, due 2026

— “a-” (Excellent) on JPY 9 billion 3.099% senior unsecured notes, due 2027

— “a-” (Excellent) on $500 million 5.75% senior unsecured notes, due 2033

— “a-” (Excellent) on $350 million 6.625% senior unsecured notes, due 2040

— “a-” (Excellent) on $325 million 5.80% senior unsecured notes, due 2041

— “a-” (Excellent) on $895.8 million 3.905% senior unsecured notes, due 2047

— “a-” (Excellent) on $1.039 billion 3.935% senior unsecured notes, due 2049

— “bbb” (Good) on $750 million 4.5% fixed to floating junior subordinated notes, due 2047

— “bbb” (Good) on $1.0 billion 5.70% junior subordinated notes, due 2048

— “bbb” (Good) on $800 million 3.70% junior subordinated notes, due 2050

— “bbb” (Good) on $1.0 billion 5.125% junior subordinated notes, due 2052

— “bbb” (Good) on $1.2 billion 6.0% junior subordinated notes, due 2052

— “bbb” (Good) on $500 million 6.75% junior subordinated notes, due 2053

— “bbb” (Good) on $1.0 billion 6.5% junior subordinated notes, due 2054

— “bbb” (Good) on $500 million 5.625% junior subordinated notes, due 2058

— “bbb” (Good) on $500 million 4.125% junior subordinated notes, due 2060

— “bbb” (Good) on $300 million 5.95% junior subordinated notes, due 2062

Prudential Financial, Inc.— “a-” (Excellent) program rating

— “a-” (Excellent) on all outstanding notes issued under the program

PRICOA Global Funding I— “aa-” (Superior) program rating

— “aa-” (Superior) on all outstanding notes issued under the program

Prudential Funding, LLC— “a+” (Excellent) program rating

The following indicative Long-Term IRs have been affirmed with stable outlooks:

Prudential Financial, Inc.—

— “a-” (Excellent) on senior unsecured debt

— “bbb+” (Good) on subordinated debt

— “bbb” (Good) on preferred stock

Prudential Financial Capital Trust II and III—

— “bbb” (Good) on preferred securities

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2026 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Wayne Kaminski, FLMI, ARA, MBA

Associate Director

+1 908 882 1916

[email protected]

Kate Steffanelli

Associate Director

+1 908 882 2337

[email protected]

Christopher Sharkey

Associate Director, Public Relations

+1 908 882 2310

[email protected]

Al Slavin

Senior Public Relations Specialist

+1 908 882 2318

[email protected]

KEYWORDS: Europe United States North America New Jersey

INDUSTRY KEYWORDS: Professional Services Insurance Finance

MEDIA:

Logo
Logo

Sphere Entertainment Co. to Host Fourth Quarter and Year-End 2025 Conference Call

Sphere Entertainment Co. to Host Fourth Quarter and Year-End 2025 Conference Call

NEW YORK–(BUSINESS WIRE)–
Sphere Entertainment Co. (NYSE: SPHR) will host a conference call to discuss results for its fourth quarter and full-year ended December 31, 2025 on Thursday, February 12, 2026 at 10:00 a.m. Eastern Time. The Company will issue a press release reporting its results prior to the market opening.

To participate via telephone, please dial 888-800-3155 with the conference ID number 8089430 approximately 10 minutes prior to the call. The call will also be available via webcast at investor.sphereentertainmentco.com under the heading “Events.”

For those who are unable to participate on the conference call, you may access a recording of the call by dialing 800-770-2030 (conference ID number 8089430). The call replay will be available from 1:00 p.m. Eastern Time on Thursday, February 12, 2026, until 11:59 p.m. Eastern Time on Thursday, February 19, 2026. The webcast replay will be available on the website until Thursday, February 19, 2026.

About Sphere Entertainment Co.

Sphere Entertainment Co. is a leader in immersive experiences, technology and media. The Company includes Sphere, an experiential medium powered by advanced technologies. The first Sphere opened in Las Vegas, with a second venue planned for Abu Dhabi. In addition, the Company includes MSG Networks, which operates two regional sports and entertainment networks, MSG Network and MSG Sportsnet, as well as a direct-to-consumer and authenticated streaming product, MSG+, delivering a wide range of live sports content and other programming. More information is available at www.sphereentertainmentco.com.

Ari Danes, CFA

Investor Relations

(212) 465-6072

Grace Kaminer

Investor Relations

(212) 631-5076

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Technology General Sports Sports Entertainment Communications Audio/Video Events/Concerts Media TV and Radio

MEDIA:

Logo
Logo

Dr. Joseph Chang Launches Update to Bestselling Book “The Aging Myth” With 15 More Years of Breakthrough Research on Cellular Wellness

Dr. Joseph Chang Launches Update to Bestselling Book “The Aging Myth” With 15 More Years of Breakthrough Research on Cellular Wellness

The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevity

PROVO, Utah–(BUSINESS WIRE)–
Nu Skin Enterprises Inc. (NYSE: NUS) today announced the relaunch of “The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young,” the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin’s Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin’s science-led innovations — from ageLOC® technology to the company’s intelligent beauty and wellness platform centered on Prysm iO™.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206515806/en/

Dr. Joseph Chang of Nu Skin with his relaunched bestselling book, The Aging Myth. Many of the discoveries in his new book were instrumental in the development of the Prysm iO intelligent wellness platform.

Dr. Joseph Chang of Nu Skin with his relaunched bestselling book, The Aging Myth. Many of the discoveries in his new book were instrumental in the development of the Prysm iO intelligent wellness platform.

Originally published in 2011, “The Aging Myth” challenged conventional wisdom by proving that aging isn’t about genetic destiny, but about how our genes function. It helps readers understand the science behind their healthspan, or the number of healthy years they live. As people live longer, the concept of wellness is becoming focused on the quality of health during those years. The book quickly became a hit, reaching #2 on The New York Times Best Seller List in its first week and securing the #1 spot at Barnes & Noble, and top rankings on Amazon, Borders and The Wall Street Journal best seller lists.

“The fundamental premise remains unchanged: we are not prisoners of our genetics,” said Dr. Chang. “However, the science of aging has evolved tremendously since 2011. This updated edition reflects over 15 years of additional research that continues to validate our core message: aging is biology in motion, and biology can be influenced. When wellness becomes measurable, it transforms from rhetoric into science.”

The new edition builds on the original by featuring expanded chapters on cellular resilience, oxidative stress management and the role of measurable biomarkers in health optimization. The updated content addresses how modern technology enables individuals to move beyond subjective feelings about health to objective, measurable insights about their biological age and cellular function. Dr. Chang draws from his experience guiding Nu Skin’s quarter-century commitment to evidence-driven wellness research, including breakthrough technologies like the Prysm iO intelligent wellness platform, a non-invasive skin carotenoid measurement device, which provides intelligent insights into an individual’s nutritional health.

“For years, Dr. Chang’s work has guided Nu Skin’s commitment to evidence-based innovation,” said Ryan Napierski, president and CEO. “What makes this relaunch so timely is how closely the research aligns with where Nu Skin is today as we work toward our vision to become the world’s leading intelligent beauty and wellness platform. This updated edition shows how the concepts introduced more than a decade ago have matured into a fully realized ecosystem — one where intelligent devices, targeted nutrition and personalized insights work together to support healthier aging. We believe this book provides the scientific foundation for the next decade of intelligent beauty and wellness.”

The digital edition of “The Aging Myth” is available through Amazon Kindle and other major online book retailers beginning today for $9.99.

About The Author

Joseph Y. Chang, Ph.D., was appointed chair of the Nu Skin Scientific Advisory Board in 2024. Prior to that, he served as Nu Skin’s chief scientific officer and executive vice president of product development for 18 years. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research, including the New York Times best seller, The Aging Myth. With over 35 years of experience in the pharmaceutical and dietary supplement industries, Joe enjoys a comprehensive knowledge of both industries. Prior to the acquisition of Pharmanex by Nu Skin Enterprises in 1998, he served as the vice president of clinical studies and pharmacology at Pharmanex.

He has also held various research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies, where he was involved in researching natural products for arthritis and immunosuppressive treatment. He received a B.S. degree from Portsmouth University and a Ph.D. from the University of London.

About Nu Skin Enterprises Inc.

The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

Media: [email protected], (801) 345-6397

Investors: [email protected], (801) 345-3577

KEYWORDS: United States North America Utah

INDUSTRY KEYWORDS: Biotechnology Health Specialty Entertainment Books Cosmetics Research Retail Genetics Fitness & Nutrition Science

MEDIA:

Photo
Photo
Dr. Joseph Chang of Nu Skin with his relaunched bestselling book, The Aging Myth. Many of the discoveries in his new book were instrumental in the development of the Prysm iO intelligent wellness platform.
Logo
Logo